Drug Regimen Review Conducted With Follow-Up for Identified Issues - Post-Acute Care
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Percentage of home health quality episodes in which a drug regimen review was conducted at the start of care or resumption of care and completion of recommended actions from timely follow-up with a physician occurred each time potential clinically significant medication issues were identified throughout that quality episode.
Numerator
Number of quality episodes in which: 1) The agency conducted a drug regimen review at the start of care or resumption of care or the patient is not taking any medications and 2) If potential clinically significant medication issues were identified at any time during the quality episode, then the home health agency contacted a physician (or physician-designee) and completed prescribed/recommended actions by midnight of the next calendar day in response to all the identified issues throughout the quality episode.
Denominator
Number of quality episodes ending with a discharge or, transfer to an inpatient facility, or death at home during the reporting period.
Exclusions
None
Use of Risk Adjustment
Risk Adjustments
None
Stratifications
None
Data Attributes
Type of Data Collection
Data Collection Methods
Outcome and Assessment Information Set (OASIS). Entry of home health service and the last 5 days of every 60 day period beginning with the start of care date.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Home Health Quality Reporting (CMS and providers) CMS Care Compare - Home health services and CMS Provider Compare (CMS, providers and publicly reported online).